Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 803

1.

Brain protein changes in Mecp2 mouse mutant models: Effects on disease progression of Mecp2 brain specific gene reactivation.

Cortelazzo A, De Felice C, Guy J, Timperio AM, Zolla L, Guerranti R, Leoncini S, Signorini C, Durand T, Hayek J.

J Proteomics. 2020 Jan 6;210:103537. doi: 10.1016/j.jprot.2019.103537. Epub 2019 Oct 16.

PMID:
31629059
2.

The Isometric Midthigh Pull in Basketball: An Effective Predictor of Sprint and Jump Performance in Male, Adolescent Players.

Scanlan AT, Wen N, Guy JH, Elsworthy N, Lastella M, Pyne DB, Conte D, Dalbo VJ.

Int J Sports Physiol Perform. 2019 Oct 10:1-7. doi: 10.1123/ijspp.2019-0107. [Epub ahead of print]

PMID:
31605523
3.

An underappreciated risk of an airway exchange catheter.

Foglia J, Guy J.

Can J Anaesth. 2019 Oct 11. doi: 10.1007/s12630-019-01504-7. [Epub ahead of print] No abstract available.

PMID:
31605290
4.

Mapping Brain-Wide Afferent Inputs of Parvalbumin-Expressing GABAergic Neurons in Barrel Cortex Reveals Local and Long-Range Circuit Motifs.

Hafner G, Witte M, Guy J, Subhashini N, Fenno LE, Ramakrishnan C, Kim YS, Deisseroth K, Callaway EM, Oberhuber M, Conzelmann KK, Staiger JF.

Cell Rep. 2019 Sep 24;28(13):3450-3461.e8. doi: 10.1016/j.celrep.2019.08.064.

5.

Lack of influence by endosymbiont Wolbachia on virus titer in the common bed bug, Cimex lectularius.

Fisher ML, Levine JF, Guy JS, Mochizuki H, Breen M, Schal C, Watson DW.

Parasit Vectors. 2019 Sep 9;12(1):436. doi: 10.1186/s13071-019-3694-2.

6.

Patterns of ovarian cancer and uterine cancer mortality and incidence in the contiguous USA.

Amin RW, Ross AM, Lee J, Guy J, Stafford B.

Sci Total Environ. 2019 Aug 28;697:134128. doi: 10.1016/j.scitotenv.2019.134128. [Epub ahead of print]

PMID:
31479898
7.

Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma.

Singal AG, Rich NE, Mehta N, Branch AD, Pillai A, Hoteit M, Volk M, Odewole M, Scaglione S, Guy J, Said A, Feld JJ, John BV, Frenette C, Mantry P, Rangnekar AS, Oloruntoba O, Leise M, Jou JH, Bhamidimarri KR, Kulik L, Ioannou GN, Huang A, Tran T, Samant H, Dhanasekaran R, Duarte-Rojo A, Salgia R, Eswaran S, Jalal P, Flores A, Satapathy SK, Kagan S, Gopal P, Wong R, Parikh ND, Murphy CC.

Gastroenterology. 2019 Nov;157(5):1253-1263.e2. doi: 10.1053/j.gastro.2019.07.040. Epub 2019 Jul 30.

PMID:
31374215
8.

Transposition favors the generation of large effect mutations that may facilitate rapid adaption.

Quadrana L, Etcheverry M, Gilly A, Caillieux E, Madoui MA, Guy J, Bortolini Silveira A, Engelen S, Baillet V, Wincker P, Aury JM, Colot V.

Nat Commun. 2019 Jul 31;10(1):3421. doi: 10.1038/s41467-019-11385-5.

9.

Use of 4D-CT for radiotherapy planning and reality in France: Data from a national survey.

De Oliveira Duarte S, Rancoule C, He MY, Baury M, Sotton S, Vallard A, Espenel S, Guy JB, Guillaume É, Vial N, Magné N, Rehailia-Blanchard A.

Cancer Radiother. 2019 Sep;23(5):395-400. doi: 10.1016/j.canrad.2019.02.006. Epub 2019 Jul 19.

PMID:
31331842
10.

Special Focus on Stage IV Cervical Cancer Patients: A Decade Experience.

Espenel S, Garcia MA, Langrand-Escure J, Vallard A, Trone JC, Rancoule C, Vial N, Moreno-Acosta P, Chauleur C, Boutet C, Peoc Apos H M, Prevot-Bitot N, Guy JB, Magné N.

Oncology. 2019;97(3):125-134. doi: 10.1159/000500025. Epub 2019 Jul 2.

PMID:
31266037
11.

Response to the letter from Dr Philippe Meurin in response to the article entitled "Incidence of major adverse cardiac events in men wishing to continue competitive sport following percutaneous coronary intervention" by Guy et al.

Carré F, Guy JM, Schnell F.

Arch Cardiovasc Dis. 2019 Jun - Jul;112(6-7):452-453. doi: 10.1016/j.acvd.2019.04.006. Epub 2019 Jun 8. No abstract available.

PMID:
31182371
12.

Chemoradiation phase II trials: re-exploring a world of missed opportunities.

Trone JC, Langrand-Escure J, Ollier E, Jmour O, Ben Mrad M, Nevesny S, Lei Q, Benna M, Yazid D, Guy JB, Vallard A, Magné N.

Acta Oncol. 2019 Aug;58(8):1158-1162. doi: 10.1080/0284186X.2019.1605194. Epub 2019 May 10.

PMID:
31074314
13.

[Complementary and alternative medicines in cancer patients].

Bosacki C, Vallard A, Gras M, Daguenet E, Morisson S, Méry B, Jmour O, Guy JB, Magné N.

Bull Cancer. 2019 May;106(5):479-491. doi: 10.1016/j.bulcan.2019.02.011. Epub 2019 Apr 23. Review. French.

PMID:
31023481
14.

Quality insurance in head and neck cancer multidisciplinary team meetings: A watchful eye on real-life experience.

Guy JB, Benna M, Xia Y, Daguenet E, Ben Mrad M, Jmour O, Vial N, Lelonge Y, Fournel P, Prades JM, Vallard A, Magné N.

Oral Oncol. 2019 Apr;91:35-38. doi: 10.1016/j.oraloncology.2019.02.020. Epub 2019 Feb 26.

PMID:
30926060
15.

A mixed methods exploratory study tackling smoking during pregnancy in an urban Aboriginal and Torres Strait Islander primary health care service.

Askew DA, Guy J, Lyall V, Egert S, Rogers L, Pokino LA, Manton-Williams P, Schluter PJ.

BMC Public Health. 2019 Mar 25;19(1):343. doi: 10.1186/s12889-019-6660-1.

16.

[Medical prevention and treatment of radiation-induced urological and nephrological complications].

Rehailia-Blanchard A, He MY, Rancoule C, Guillaume É, Guy JB, Vial N, Nivet A, Orliac H, Chargari C, Magné N.

Cancer Radiother. 2019 Apr;23(2):151-160. doi: 10.1016/j.canrad.2018.05.007. Epub 2019 Mar 18. Review. French.

PMID:
30898418
17.

Metal-Assisted and Microwave-Accelerated Decrystallization of Pseudo-Tophus in Synthetic Human Joint Models.

Boone-Kukoyi Z, Moody K, Nwawulu C, Ariori R, Ajifa H, Guy JA, Lansiquot C, Ozturk B, McLemore GL, Bonyi E, Aslan K.

ACS Omega. 2019 Feb 28;4(2):4417-4428. doi: 10.1021/acsomega.8b03497.

18.

[LHRH analogs in adjuvant endocrine therapy for pre-menopausal localized breast cancers: Ending the controversy for novel guidelines?]

Daguenet E, Jmour O, Vallard A, Guy JB, Jacquin JP, Méry B, Magné N.

Bull Cancer. 2019 Apr;106(4):342-353. doi: 10.1016/j.bulcan.2019.01.012. Epub 2019 Mar 8. Review. French.

PMID:
30853114
19.

Serpin B1 defect and increased apoptosis of neutrophils in Cohen syndrome neutropenia.

Duplomb L, Rivière J, Jego G, Da Costa R, Hammann A, Racine J, Schmitt A, Droin N, Capron C, Gougerot-Pocidalo MA, Dubrez L, Aral B, Lafon A, Edery P, Ghoumid J, Blair E, El Chehadeh-Djebbar S, Carmignac V, Thevenon J, Guy J, Girodon F, Bastie JN, Delva L, Faivre L, Thauvin-Robinet C, Solary E.

J Mol Med (Berl). 2019 May;97(5):633-645. doi: 10.1007/s00109-019-01754-4. Epub 2019 Mar 7.

PMID:
30843084
20.

Is breast-conserving therapy adequate in BRCA 1/2 mutation carriers? The radiation oncologist's point of view.

Vallard A, Magné N, Guy JB, Espenel S, Rancoule C, Diao P, Deutsch E, Rivera S, Chargari C.

Br J Radiol. 2019 May;92(1097):20170657. doi: 10.1259/bjr.20170657. Epub 2019 Feb 27. Review.

PMID:
30810334
21.

Value of combined spherocytose osmotic and EMA tests in the diagnosis of hereditary spherocytosis.

Cheli E, Roze J, Daouairi N, Racine J, Guy J, Ghazal K, Picard V, Girodon F.

Int J Lab Hematol. 2019 Aug;41(4):e84-e85. doi: 10.1111/ijlh.12976. Epub 2019 Feb 7. No abstract available.

PMID:
30730613
22.

The spectrum of spinal cord lesions in a primate model of multiple sclerosis.

Lefeuvre JA, Guy JR, Luciano NJ, Ha SK, Leibovitch E, Santin MD, Silva AC, Jacobson S, Lehéricy S, Reich DS, Sati P.

Mult Scler. 2019 Feb 7:1352458518822408. doi: 10.1177/1352458518822408. [Epub ahead of print]

PMID:
30730246
23.

Peripheral blood minimal/measurable residual disease assessed in flow cytometry in acute myeloblastic leukemia.

Guénot C, Lacombe F, Allou K, Dumezy F, Feuillard J, Geneviève F, Guérin E, Guy J, Maynadié M, Ballon OW, Preudhomme C, Baruchel A, Dombret H, Ifrah N, Béné MC; Groupe d’Etude Immunologique des Leucémies (GEIL).

Leukemia. 2019 Jul;33(7):1814-1816. doi: 10.1038/s41375-019-0393-0. Epub 2019 Feb 5. No abstract available.

PMID:
30723257
24.

Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study.

Singal AG, Rich NE, Mehta N, Branch A, Pillai A, Hoteit M, Volk M, Odewole M, Scaglione S, Guy J, Said A, Feld JJ, John BV, Frenette C, Mantry P, Rangnekar AS, Oloruntoba O, Leise M, Jou JH, Bhamidimarri KR, Kulik L, Tran T, Samant H, Dhanasekaran R, Duarte-Rojo A, Salgia R, Eswaran S, Jalal P, Flores A, Satapathy SK, Wong R, Huang A, Misra S, Schwartz M, Mitrani R, Nakka S, Noureddine W, Ho C, Konjeti VR, Dao A, Nelson K, Delarosa K, Rahim U, Mavuram M, Xie JJ, Murphy CC, Parikh ND.

Gastroenterology. 2019 May;156(6):1683-1692.e1. doi: 10.1053/j.gastro.2019.01.027. Epub 2019 Jan 18.

PMID:
30660729
25.

Evaluation of TAK-264, an Antibody-Drug Conjugate in Pancreatic Cancer Cell Lines and Patient-Derived Xenograft Models.

Schreiber AR, Nguyen A, Bagby SM, Arcaroli JJ, Yacob BW, Quackenbush K, Guy JL, Crowell T, Stringer B, Danaee H, Kalebic T, Messersmith WA, Pitts TM.

Clin Cancer Drugs. 2018;5(1):42-49. doi: 10.2174/2212697X05666180516120907.

26.

[Innovation in radiotherapy: A glance at 2018].

Vial N, Vallard A, Jmour O, Rehailia-Blanchard A, Ben Mrad M, Trone JC, Daguenet E, Guy JB, Magné N.

Bull Cancer. 2019 Jan;106(1):48-54. doi: 10.1016/j.bulcan.2018.12.006. Epub 2019 Jan 4. Review. French.

PMID:
30616840
27.

Incidence of major adverse cardiac events in men wishing to continue competitive sport following percutaneous coronary intervention.

Guy JM, Wilson M, Schnell F, Chevalier L, Verdier JC, Corone S, Doutreleau S, Kervio G, Carré F.

Arch Cardiovasc Dis. 2019 Apr;112(4):226-233. doi: 10.1016/j.acvd.2018.11.008. Epub 2019 Jan 3.

PMID:
30612894
28.

Radiothérapie et immunothérapie.

Rancoule C, Vallard A, Jmour O, Vial N, Guillaume E, Guy JB, Magné N.

Bull Cancer. 2018 Dec;105 Suppl 1:S92-S100. doi: 10.1016/S0007-4551(18)30394-1. Review. French.

PMID:
30595203
29.

Cancer du rein et radiothérapie : radiorésistance et au-delà.

Mery B, Rancoule C, Rowinski E, Bosacki C, Vallard A, Guy JB, Magné N.

Bull Cancer. 2018 Dec;105 Suppl 3:S280-S285. doi: 10.1016/S0007-4551(18)30383-7. Review. French.

PMID:
30595157
30.

Toxicity of overexpressed MeCP2 is independent of HDAC3 activity.

Koerner MV, FitzPatrick L, Selfridge J, Guy J, De Sousa D, Tillotson R, Kerr A, Sun Z, Lazar MA, Lyst MJ, Bird A.

Genes Dev. 2018 Dec 1;32(23-24):1514-1524. doi: 10.1101/gad.320325.118. Epub 2018 Nov 21.

31.

Multicenter validation of the flow measurement of classical monocyte fraction for chronic myelomonocytic leukemia diagnosis.

Tarfi S, Harrivel V, Dumezy F, Guy J, Roussel M, Mimoun A, Fenaux P, Chapuis N, Solary E, Selimoglu-Buet D, Wagner-Ballon O; Groupe Francophone des Myélodysplasies (GFM).

Blood Cancer J. 2018 Nov 14;8(11):114. doi: 10.1038/s41408-018-0146-8.

32.

A systematic review examining the physiological, perceptual, and performance effects of active and passive recovery modes applied between repeated-sprints.

Madueno MC, Guy JH, Dalbo VJ, Scanlan AT.

J Sports Med Phys Fitness. 2019 Sep;59(9):1492-1502. doi: 10.23736/S0022-4707.18.09188-0. Epub 2018 Nov 8.

PMID:
30421874
33.

Pezizomycetes genomes reveal the molecular basis of ectomycorrhizal truffle lifestyle.

Murat C, Payen T, Noel B, Kuo A, Morin E, Chen J, Kohler A, Krizsán K, Balestrini R, Da Silva C, Montanini B, Hainaut M, Levati E, Barry KW, Belfiori B, Cichocki N, Clum A, Dockter RB, Fauchery L, Guy J, Iotti M, Le Tacon F, Lindquist EA, Lipzen A, Malagnac F, Mello A, Molinier V, Miyauchi S, Poulain J, Riccioni C, Rubini A, Sitrit Y, Splivallo R, Traeger S, Wang M, Žifčáková L, Wipf D, Zambonelli A, Paolocci F, Nowrousian M, Ottonello S, Baldrian P, Spatafora JW, Henrissat B, Nagy LG, Aury JM, Wincker P, Grigoriev IV, Bonfante P, Martin FM.

Nat Ecol Evol. 2018 Dec;2(12):1956-1965. doi: 10.1038/s41559-018-0710-4. Epub 2018 Nov 12.

34.

Venous thromboembolic events during warm autoimmune hemolytic anemia.

Audia S, Bach B, Samson M, Lakomy D, Bour JB, Burlet B, Guy J, Duvillard L, Branger M, Leguy-Seguin V, Berthier S, Michel M, Bonnotte B.

PLoS One. 2018 Nov 8;13(11):e0207218. doi: 10.1371/journal.pone.0207218. eCollection 2018.

35.

Outcomes and treatments of IB1 cervical cancers with high recurrence risk: A 13 years' experience.

Espenel S, Garcia MA, Vallard A, Langrand-Escure J, Guy JB, Trone JC, Ben Mrad M, Chauleur C, de Laroche G, Moreno-Acosta P, Rancoule C, Magné N.

Cancer Radiother. 2018 Dec;22(8):790-796. doi: 10.1016/j.canrad.2018.03.006. Epub 2018 Oct 19.

PMID:
30348607
36.

Herpesvirus trigger accelerates neuroinflammation in a nonhuman primate model of multiple sclerosis.

Leibovitch EC, Caruso B, Ha SK, Schindler MK, Lee NJ, Luciano NJ, Billioux BJ, Guy JR, Yen C, Sati P, Silva AC, Reich DS, Jacobson S.

Proc Natl Acad Sci U S A. 2018 Oct 30;115(44):11292-11297. doi: 10.1073/pnas.1811974115. Epub 2018 Oct 15.

37.

Pharmacy student awareness, aspiration, and preparation for post graduate education (PGE) fellowship in US: A cross-sectional study.

Patel I, Guy JW, Han Y, Paraoan J, Marsh W, Johnson MS.

Curr Pharm Teach Learn. 2018 Aug;10(8):1055-1061. doi: 10.1016/j.cptl.2018.05.006. Epub 2018 Jun 13.

PMID:
30314541
38.

[Place of the exercise stress test at the sportsman].

Chevalier L, Guy JM, Doutreleau S.

Ann Cardiol Angeiol (Paris). 2018 Nov;67(5):361-364. doi: 10.1016/j.ancard.2018.08.013. Epub 2018 Oct 6. Review. French.

PMID:
30301545
39.

Measuring Decrement in Change-of-Direction Speed Across Repeated Sprints in Basketball: Novel vs. Traditional Approaches.

Scanlan AT, Madueno MC, Guy JH, Giamarelos K, Spiteri T, Dalbo VJ.

J Strength Cond Res. 2018 Sep 17. doi: 10.1519/JSC.0000000000002792. [Epub ahead of print]

PMID:
30234693
40.

Pathologic Subtypes of Lung Adenocarcinoma Brain Metastasis Is a Strong Predictor of Survival After Resection.

Casteillo F, Guy JB, Dal-Col P, Karpathiou G, Pommier B, Bayle-Bleuez S, Fournel P, Vassal F, Forest F.

Am J Surg Pathol. 2018 Dec;42(12):1701-1707. doi: 10.1097/PAS.0000000000001161.

PMID:
30222604
41.

Affinity for DNA Contributes to NLS Independent Nuclear Localization of MeCP2.

Lyst MJ, Ekiert R, Guy J, Selfridge J, Koerner MV, Merusi C, De Sousa D, Bird A.

Cell Rep. 2018 Aug 28;24(9):2213-2220. doi: 10.1016/j.celrep.2018.07.099.

42.

Impact of active and passive social facilitation on self-paced endurance and sprint exercise: encouragement augments performance and motivation to exercise.

Edwards AM, Dutton-Challis L, Cottrell D, Guy JH, Hettinga FJ.

BMJ Open Sport Exerc Med. 2018 Jul 27;4(1):e000368. doi: 10.1136/bmjsem-2018-000368. eCollection 2018.

43.

Monitor for strictures after radiofrequency ablation.

Guy JL.

Nursing. 2018 Aug;48(8):8. doi: 10.1097/01.NURSE.0000541400.13094.ad. No abstract available.

PMID:
30045230
44.

Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey.

Langrand-Escure J, Diao P, Garcia MA, Wang G, Guy JB, Espenel S, Guillaume E, Rehailia-Blanchard A, Pigné G, de Laroche G, Kaczmarek D, Muron T, Porcheron J, Phelip JM, Vallard A, Magné N.

Sci Rep. 2018 Jul 16;8(1):10708. doi: 10.1038/s41598-018-29040-2.

45.

Effects of Ebola Virus Disease education on student health professionals.

Patel I, Guy J, Han Y, Marsh W, Pierce R, Johnson MS.

Curr Pharm Teach Learn. 2018 May;10(5):651-656. doi: 10.1016/j.cptl.2018.01.011. Epub 2018 Mar 26.

PMID:
29986826
46.

Harnessing drug/radiation interaction through daily routine practice: Leverage medical and methodological point of view (MORSE 02-17 study).

Vallard A, Rancoule C, Espenel S, Garcia MA, Langrand-Escure J, He MY, Ben Mrad M, El Meddeb Hamrouni A, Ouni S, Trone JC, Rehailia-Blanchard A, Guillaume E, Vial N, Riocreux C, Guy JB, Magné N.

Radiother Oncol. 2018 Dec;129(3):471-478. doi: 10.1016/j.radonc.2018.06.010. Epub 2018 Jun 21.

PMID:
29937210
47.

Nutrition and Supplementation Considerations to Limit Endotoxemia When Exercising in the Heat.

Guy JH, Vincent GE.

Sports (Basel). 2018 Feb 6;6(1). pii: E12. doi: 10.3390/sports6010012. Review.

48.

Outcomes prediction in pre-operative radiotherapy locally advanced rectal cancer: leucocyte assessment as immune biomarker.

Vallard A, Garcia MA, Diao P, Espenel S, de Laroche G, Guy JB, Mrad MB, Rancoule C, Kaczmarek D, Muron T, Pigné G, Porcheron J, Peoc'h M, Phelip JM, Langrand-Escure J, Magné N.

Oncotarget. 2018 Apr 27;9(32):22368-22382. doi: 10.18632/oncotarget.25023. eCollection 2018 Apr 27.

49.

Differential attenuation of Marek's disease virus-induced tumours and late-Marek's disease virus-induced immunosuppression.

Faiz NM, Cortes AL, Guy JS, Reddy SM, Gimeno IM.

J Gen Virol. 2018 May 16. doi: 10.1099/jgv.0.001076. [Epub ahead of print]

PMID:
29767614
50.

Biological aspects of chondrosarcoma: Leaps and hurdles.

Mery B, Espenel S, Guy JB, Rancoule C, Vallard A, Aloy MT, Rodriguez-Lafrasse C, Magné N.

Crit Rev Oncol Hematol. 2018 Jun;126:32-36. doi: 10.1016/j.critrevonc.2018.03.009. Epub 2018 Mar 22. Review.

PMID:
29759564

Supplemental Content

Support Center